What question did this study set out to answer?

The primary aim is to assess the prevalence and localization of clonal hematopoiesis and lymphoma-related mutations in B-cell lymphoma patients.

April 12, 2026Blood0 citationsOpen Access

Digging deep for the roots of lymphoma

JSJoseph Schroers-MartinStanford University

Key Points

The primary aim is to assess the prevalence and localization of clonal hematopoiesis and lymphoma-related mutations in B-cell lymphoma patients.
Evaluated a cohort of patients with B-cell lymphomas
Analyzed clonal mutations linked to lymphoid disease and their hematopoietic localization
Compared the frequency of lymphoid-specific mutations with myeloid malignancies
Lymphoid-specific clonal mutations occur less frequently than myeloid clonal hematopoiesis
These mutations are linked to a higher risk of developing subsequent lymphoid cancers

Abstract

In this issue of Blood, Wiegand et al 1 evaluate the prevalence and hematopoietic localization of clonal hematopoiesis (CH) and lymphoma-associated mutations in a cohort of patients with B-cell lymphomas.Although the association between CH and myeloid malignancy is well established, data regarding lymphoid disease are more limited.Lymphoid-specific clonal mutations appear less frequent than canonical myeloid CH in the general population but are associated with an increased risk of subsequent lymphoid cancers. 2

Ask AI

Helpful

Bookmark

View Full Paper